‌

US Patent 9499538 Estrogen receptor modulators and uses thereof

Patent 9499538 was granted and assigned to Seragon Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Seragon Pharmaceuticals

Current Assignee

Seragon Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94995380

Patent Inventor Names

Johnny Y. Nagasawa0

Mehmet Kahraman0

Karensa L. Douglas0

Steven P. Govek0

Nicholas D. Smith0

Andiliy G. Lai0

Celine Bonnefous0

Jackaline D. Julien0

Date of Patent

November 22, 2016

Patent Application Number

143863130

Date Filed

March 14, 2013

Patent Primary Examiner

‌

Joseph Kosack

Patent abstract

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9499538 Estrogen receptor modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API